首页> 外文期刊>Journal of Coordination Chemistry >Synthesis and in vitro cytotoxicity of novel dinuclear platinum(II) complexes containing a chiral tetradentate ligand
【24h】

Synthesis and in vitro cytotoxicity of novel dinuclear platinum(II) complexes containing a chiral tetradentate ligand

机译:含有手性四元戊酸配体的新型二核铂(II)配合物的合成和体外细胞毒性

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel dinuclear platinum(II) complexes with a chiral tetradentate ligand, (1R, 1'R, 2R, 2'R)-N-1, N-1'-(1,2-phenylenebis(methylene))dicyclohexane-1,2-diamine (HL), and mono-carboxylic acid derivatives as ligands have been designed, synthesized, and characterized. In vitro cytotoxicity evaluation of synthesized complexes against human HepG2, A549, HCT-116, and MCF-7 cancer cell lines has been conducted by MTT assays. All compounds showed antitumor activity to HepG-2 and HCT-116 cell lines. Compound L2 exhibited better cytotoxicity than that of carboplatin against HepG-2 and A549 cell lines and also showed comparable activity against HCT-116 cell line.
机译:一系列新型的二核铂(II)配合物,具有手性四环配体,(1R,1'R,2R,2'R)-N-1,N-1' - (1,2-亚苯基)二环己烷 为配体设计,合成和表征为配体-1,2-二胺(H1)和单羧酸衍生物。 通过MTT测定进行了对人HepG2,A549,HCT-116和MCF-7癌细胞系的合成复合物的体外细胞毒性评价。 所有化合物都显示出抗肿瘤活性至HepG-2和HCT-116细胞系。 化合物L2表现出比HEPG-2和A549细胞系的卡铂的更好的细胞毒性,并且还显示出对HCT-116细胞系的相当活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号